Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.6% |
| 2 | Technology | 19.83% |
| 3 | Financials | 7.37% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1426
Royalty Pharma
RPRX
$25.5B
| $12.2M | ﹤0.01% |
339,362
-27,868
| -8% | -$923K |
2022 Q1
13 quarters
|
|
|
BPMC
1427
CALL
DELISTED
Blueprint Medicines
BPMC
| $12.2M | ﹤0.01% |
+95,300
| New | +$9.9M |
2025 Q2
0 quarters
|
|
1428
Moog Inc Class A
MOG.A
$12.4B
| $12.2M | ﹤0.01% |
67,477
+14,487
| +27% | +$2.54M |
2013 Q2
48 quarters
|
|
1429
PUT
Dow Inc
DOW
$20.2B
| $12.2M | ﹤0.01% |
+460,000
| New | +$13.4M |
2025 Q2
0 quarters
|
|
1430
Lithia Motors
LAD
$6.77B
| $12.2M | ﹤0.01% |
36,040
+12,717
| +55% | +$3.93M |
2013 Q2
48 quarters
|
|
1431
Applied Industrial Technologies
AIT
$12.6B
| $12.2M | ﹤0.01% |
52,376
-14,241
| -21% | -$3.24M |
2016 Q1
37 quarters
|
|
1432
Sabra Healthcare REIT
SBRA
$4.89B
| $12.2M | ﹤0.01% |
659,978
-526,038
| -44% | -$9.33M |
2013 Q2
48 quarters
|
|
1433
OGE Energy
OGE
$9.37B
| $12.1M | ﹤0.01% |
273,706
+182,172
| +199% | +$8.08M |
2013 Q2
48 quarters
|
|
1434
Omnicell
OMCL
$1.53B
| $12.1M | ﹤0.01% |
412,570
+32,832
| +9% | +$982K |
2013 Q2
48 quarters
|
|
1435
Itron
ITRI
$3.79B
| $12.1M | ﹤0.01% |
91,903
+17,675
| +24% | +$2M |
2013 Q2
48 quarters
|
|
1436
Coherent
COHR
$66B
| $12.1M | ﹤0.01% |
135,540
-26,280
| -16% | -$1.89M |
2013 Q2
48 quarters
|
|
1437
ANI Pharmaceuticals
ANIP
$1.66B
| $12M | ﹤0.01% |
184,639
+45,359
| +33% | +$2.95M |
2013 Q2
48 quarters
|
|
|
BCPC
1438
Balchem Corp
BCPC
$5.31B
| $12M | ﹤0.01% |
75,594
+26,274
| +53% | +$4.26M |
2016 Q3
35 quarters
|
|
1439
Blue Owl Capital
OWL
$6.21B
| $12M | ﹤0.01% |
625,030
+195,660
| +46% | +$3.62M |
2022 Q1
13 quarters
|
|
|
ETOR
1440
CALL
eToro Group
ETOR
$2.02B
| $12M | ﹤0.01% |
+180,000
| New | +$11.6M |
2025 Q2
0 quarters
|
|
1441
CareTrust REIT
CTRE
$8.58B
| $12M | ﹤0.01% |
391,348
+103,085
| +36% | +$2.97M |
2014 Q2
44 quarters
|
|
1442
Cal-Maine
CALM
$3.11B
| $12M | ﹤0.01% |
120,015
+46,186
| +63% | +$4.41M |
2013 Q2
48 quarters
|
|
|
WCC
1443
WESCO International
WCC
$18.6B
| $12M | ﹤0.01% |
64,562
+9,162
| +17% | +$1.51M |
2013 Q2
48 quarters
|
|
1444
iShares 3-7 Year Treasury Bond ETF
IEI
$17.2B
| $12M | ﹤0.01% |
100,356
+62,356
| +164% | +$7.36M |
2025 Q1
1 quarter
|
|
1445
Aaon
AAON
$6.87B
| $11.9M | ﹤0.01% |
161,921
-819
| -0.5% | -$71.8K |
2016 Q1
37 quarters
|
|
1446
Reinsurance Group of America
RGA
$16.3B
| $11.9M | ﹤0.01% |
60,180
-20,469
| -25% | -$4M |
2013 Q2
48 quarters
|
|
1447
ONE Gas
OGS
$4.56B
| $11.9M | ﹤0.01% |
166,047
+59,391
| +56% | +$4.46M |
2014 Q1
45 quarters
|
|
1448
Revolve Group
RVLV
$1.48B
| $11.9M | ﹤0.01% |
594,138
+18,703
| +3% | +$379K |
2019 Q2
24 quarters
|
|
1449
CALL
Affirm
AFRM
$23.9B
| $11.9M | ﹤0.01% |
172,200
-27,800
| -14% | -$1.44M |
2024 Q2
4 quarters
|
|
1450
Cedar Fair
FUN
$1.19B
| $11.9M | ﹤0.01% |
391,022
+3,193
| +0.8% | +$107K |
2020 Q2
20 quarters
|
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2025 filing shows 461 new, 2,914 increased, 1,345 reduced and 463 closed positions. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M. The largest sale was Honeywell, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.